Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehul R Dalal

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Medical Research and Opinion|October 15, 2016
Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalizationMehul R Dalal, Mahmood R Kazemi, Fen Ye
The Diabetes Educator|May 4, 2013
The impact of diabetes counseling and education: clinical and cost outcomes from a large population of US managed care patients with type 2 diabetesSean D Sullivan, Mehul R Dalal, James P Burke
Advances in Therapy|August 6, 2017
Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and UtilizationMehul R Dalal, Mahmood Kazemi, Fen Ye, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 24, 2014
Adding Rapid-Acting Insulin or GLP-1 Receptor Agonist to Basal Insulin: Outcomes in a Community SettingMehul R Dalal, Lin Xie, Onur Baser, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2006
A comparison of depressive symptoms in stroke and primary care: applying Rasch models to evaluate the center for epidemiologic studies-depression scaleA Simon Pickard, Mehul R Dalal, Donald M Bushnell
Diabetes Spectrum : a Publication of the American Diabetes Association|February 4, 2015
Real-world evaluation of the effects of counseling and education in diabetes managementMehul R Dalal, Scott B Robinson, Sean D Sullivan
Diabetes Technology & Therapeutics|May 4, 2017
Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance MeasuresIldiko Lingvay, Jason Chao, Mehul R Dalal, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 23, 2013
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United StatesAlok A Khorana, Mehul R Dalal, Jay Lin, et al.
Postgraduate Medicine|April 9, 2015
Type 2 diabetes mellitus treatment patterns in U.S. nursing home residentsBarbara Zarowitz, Carrie Allen, Terrence O'Shea, et al.
Diabetes Research and Clinical Practice|September 13, 2016
Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targetsMehul R Dalal, Michael Grabner, Nicole Bonine, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|October 15, 2016
Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalizationMehul R Dalal, Mahmood R Kazemi, Fen Ye
The Diabetes Educator|May 4, 2013
The impact of diabetes counseling and education: clinical and cost outcomes from a large population of US managed care patients with type 2 diabetesSean D Sullivan, Mehul R Dalal, James P Burke
Advances in Therapy|August 6, 2017
Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and UtilizationMehul R Dalal, Mahmood Kazemi, Fen Ye, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 24, 2014
Adding Rapid-Acting Insulin or GLP-1 Receptor Agonist to Basal Insulin: Outcomes in a Community SettingMehul R Dalal, Lin Xie, Onur Baser, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 31, 2006
A comparison of depressive symptoms in stroke and primary care: applying Rasch models to evaluate the center for epidemiologic studies-depression scaleA Simon Pickard, Mehul R Dalal, Donald M Bushnell
Diabetes Spectrum : a Publication of the American Diabetes Association|February 4, 2015
Real-world evaluation of the effects of counseling and education in diabetes managementMehul R Dalal, Scott B Robinson, Sean D Sullivan
Diabetes Technology & Therapeutics|May 4, 2017
Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance MeasuresIldiko Lingvay, Jason Chao, Mehul R Dalal, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 23, 2013
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United StatesAlok A Khorana, Mehul R Dalal, Jay Lin, et al.
Postgraduate Medicine|April 9, 2015
Type 2 diabetes mellitus treatment patterns in U.S. nursing home residentsBarbara Zarowitz, Carrie Allen, Terrence O'Shea, et al.
Diabetes Research and Clinical Practice|September 13, 2016
Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targetsMehul R Dalal, Michael Grabner, Nicole Bonine, et al.
Pageof 2